FDA gives go-ahead to first sickle cell treatment in 20 years
July 10, 2017Sales and Marketing Emmaus Medical, L-glutamine, sickle cell disease
Emmaus Medical has been handed approval for the first new treatment for sickle cell disease in two decades. The active …
AstraZeneca appoint new MD for India
July 7, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, India
AstraZeneca announced a new Managing Director for AstraZeneca Pharma India, with Gagan Singh Bedi beginning the role on 3 July. …
Oral sex creating super-gonorrhoea
July 7, 2017Research and Development antibiotic resistance, gonorrhoea
The WHO has announced that data from across 77 different countries show that the sexually-transmitted infection (STI) gonorrhoea is becoming …
Top Ten most popular articles on Pharmafile.com this week
July 7, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing most read articles, most read news, top ten
It’s Friday, and we’ve brought together our weekly digest of the articles which proved most popular with our readers. Brexit …
Celgene plays catch up with $1.4 billion immunotherapy deal
July 7, 2017Medical Communications, Sales and Marketing BeiGene, Celgene, immunotherapy, pd-1
Those commentating on Celgene’s latest deal seem to be equally divided between two camps: it is too much money, too …
Top 50 Selling Products in the World by 2022
July 6, 2017Medical Communications
This article was originally published in Pharmafile Spring 2017.Opdivo and Revlimid to compete for the top spot in 2022, while …
New data shows pharma has not cut back on controversial payments to physicians
July 6, 2017Medical Communications, Sales and Marketing Allergan, Biogen, Celgene, Sanofi, Valeant
Despite increasing controversy arising over the years due to the questionable relationship between physicians and pharma and the money which …
FDA shutters MSD’s Keytruda combination trials in myeloma
July 6, 2017Medical Communications, Research and Development MSD, immunotherapy, keytruda, pd-1
Following on from the news last month that enrolment for Keytruda being used alongside Celgene’s Imnovid and Revlimid would have …
Oxford BioMedica in $100 million manufacturing deal with Novartis
July 6, 2017Manufacturing and Production, Sales and Marketing Novartis, Oxford BioMedica
Oxford BioMedica has announced that it has signed a contract with Novartis to supply the company with materials in a …
Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland
July 6, 2017Sales and Marketing Actavis, Gilead, HIV, Mylan, Truvada
Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation that they are planning to …
Atomic structure of tau revealed opening up new Alzheimer’s targets
July 6, 2017Research and Development Alzheimer's disease, dementia, tau protein, tau tangle
It is a research breakthrough that has been touted as the biggest development in Alzheimer’s disease research for a quarter …
Heart failure market to quadruple in ten years to $16 billion
July 6, 2017Sales and Marketing GlobalData, Novartis, heart failure
New research from intelligence firm GlobalData has indicated that the market for heart failure drugs is forecast to expand by …
Breakthrough in personalised medicine as cancer vaccine shows results
July 6, 2017Research and Development Precision Medicine, personalised medicine, precision oncology
The old adage that everyone is unique holds a lot of water when it comes to cancer treatment. Research has …
Merck Foundation created and CEO set in place
July 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Foundation, Merck KGaA
Merck KGaA announced that is has created the Merck Foundation and has appointed Rasha Kelej as its CEO. The role …
EMA and FDA harmonise over development of Gaucher drugs
July 5, 2017Medical Communications, Research and Development, Sales and Marketing EMA, FDA, Gaucher disease
The EMA and the FDA have announced that they have developed a joint proposal to promote more efficient means of …
NICE agrees approval deal for ultra-rare juvenile bone disease
July 5, 2017Research and Development, Sales and Marketing Alexion, NICE, Strensiq
NICE has announced that it has decided to approve Alexion Pharma’s Strensiq (asfotase alfa) for the treatment of ultra-rare disease …
Google’s DeepMind app deal with NHS brought into question
July 5, 2017Medical Communications, Research and Development Alphabet, DeepMind, NHS, google
DeepMind’s deal with the NHS to develop an app that is able to detect possible kidney damage involved 1.6 million …
Tumour genome mapping could lead to improved outcomes, research finds
July 5, 2017Research and Development Cancer, Hi-C
A research team at the Babraham Institute in Cambridge, UK has revealed a new method to detect and monitor large-scale …
Gain insight into what your peers are doing
July 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, wave
When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …
Researchers boost existing antibiotic to tackle drug resistance
July 4, 2017Research and Development University of Lincoln, antibiotic resistance
The growing issue of antibiotic resistance is finding itself increasingly central in pharma’s priorities, though many still argue that the …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
